Sign in with Google
bearish
Samsung BioLogics and Biogen: Who Had Control?
415 Views04 May 2018 14:02
The controversy surrounding Samsung Biologics Co., Ltd (207940 KS) 's booking of a fair value gain in 2015 relates to their claim of a "loss of...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Toyota Industries (6201) - Thinking About How To Value a ¥6trln Bid
- Hainan Meilan Intl Airport (357 HK): Hainan SASAC's Left/Right Pocket MGO
- StubWorld: On Valuing Toyota Industries (6201)'s Stub Ops
- Meilan Airport (357 HK): Possible Unconditional MGO at HK$10.62
- Shibaura Elec (6957) - Minebea Overbids Yageo's Overbid of Minebea's Overbid of Yageo - ¥5,500
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Last Week in Event SPACE: Samsung Biologics, Shire, Lotte, Mitula, JSW, Nisshinbo12 May 2018
- FSS Vs. Samsung BioLogics - Latest Situation Update09 May 2018
- Samsung BioLogics - Market Sentiment Assessment05 May 2018
- Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas01 May 2018
- A Conversation with Biogen12 Apr 2018
x